Jelli, B., O. Taton, N. D’Haene, M. Remmelink, and Z. Mekinda. “ Complete Response to Afatinib of an EGFR Exon 18 delE709_T710insD-Mutated Stage IV Lung Adenocarcinoma”. European Journal of Case Reports in Internal Medicine, vol. 8, no. 8, Aug. 2021, doi:10.12890/2021_002749.